What Most DTC Founders Get Wrong About Entering a Crowded Category | Greta Meyer
Unfinished Business · 2026-05-19 · 33 min
Episode notes
Greta Meyer started Sequel in a college classroom. She and her co-founder identified a physics flaw in the tampon that nobody had fixed in almost 100 years, and spent years navigating FDA clearance, manufacturing partnerships, and a medical device regulatory process most founders would have quit on. They launched DTC, spent almost nothing on ads, and built their brand through partnerships instead. Yankee Stadium reached out to them. So did the Indiana Fever. The thing that makes Sequel work is also the thing that makes it hard to copy: radical focus. They're not trying to reinvent the whole menstrual experience. They fixed one fluid mechanics problem and built everything around that. In this episode of Unfinished Business, Alex and Lee sit down with Greta to talk about what it actually takes to break into a commoditized, legacy-dominated category when you can't out-spend the incumbents and the product itself is invisible to the consumer.
More from Unfinished Business
All episodes →- How TUSHY Turned a Taboo Category Into One of DTC's Strongest Brands with Justin Allen66 / 100
- Going From $50M to $100M: How We Use Partnerships As Our Biggest Growth Levers at Hulken69 / 100
- The DTC Trap That Built Juliet Wine's Retail Empire | Allison Luvera69 / 100
- The DTC math most founders refuse to do (until it's too late) | Suze Dowling @ Pattern Brands
- Inside Hulken: How Our CBO Built a $50M Community-Led Luxury Brand